Production of a highly immunogenic subunit ISCOM vaccine against Bovine Viral Diarrhea Virus

By Kamstrup S.   Roensholt L.   Jensen M.H.   Dalsgaard K.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1057-1064

Elsevier

Access to resources Recommend Favorite

Use of fusion protein constructs to generate potent immunotherapy and protection against scorpion toxins

By Legros C.   Kaabi H.   El Ayeb M.   Ceard B.   Vacher H.   Bougis P.E.   Martin-Eauclaire M.-F.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 934-942

Elsevier

Access to resources Recommend Favorite

Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1

By O'Hagan D.T.   Ugozzoli M.   Barackman J.   Singh M.   Kazzaz J.   Higgins K.   Vancott T.C.   Ott G.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1793-1801

Elsevier

Access to resources Recommend Favorite

Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120

By Pinter A.   Honnen W.J.   Kayman S.C.   Trochev O.   Wu Z.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1803-1811

Elsevier

Access to resources Recommend Favorite

Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C

By Hewer R.   Meyer D.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2680-2683

Elsevier

Access to resources Recommend Favorite